Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

A patent perspective on US stem cell research

What are the implications of recent US Supreme Court decisions on the patent eligibility of stem cells?

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. Armstrong, L. et al. Stem Cells 30, 2–9 (2012).

    CAS  Article  Google Scholar 

  2. Schwartz, S.D. et al. Lancet 379, 713–720 (2012).

    CAS  Article  Google Scholar 

  3. Tachibana, M. et al. Cell 153, 1228–1238 (2013).

    CAS  Article  Google Scholar 

  4. Burrone, E. Patents at the core: the biotech business (2006).

  5. Bergman, K. & Graff, G.D. Nat. Biotechnol. 25, 419–424 (2007).

    CAS  Article  Google Scholar 

  6. Mayo v. Prometheus, 566 US 132 (2012).

  7. Parker v. Flook, 437 US 584 (1978).

  8. Hirshfeld, A.H. 2012 Interim Procedure for Subject Matter Eligibility Analysis of Process Claims Involving Laws of Nature (USPTO memorandum, 3 July 2012).

    Google Scholar 

  9. Rogers, E.J. J. Pat. Trademark Off. Soc. 19, 93 (2011).

    Google Scholar 

  10. Ass'n v. USPTO, 702 F. Supp. 2d 181 (S.D.N.Y., 2010).

  11. Ass'n v. USPTO, 653 F. 3d 1329 (2011).

  12. Ass'n v. USPTO, 689 F. 3d 1303 (2012).

  13. Ass'n v. Myriad, 569 US 12–398 (2013).

  14. Hirshfeld, A.H. Supreme Court Decision in Association for Molecular Pathology v. Myriad Genetics, Inc. (USPTO memorandum, 13 June 2013).

  15. Hirshfeld, A.H. 2014 Procedure for Subject Matter Eligibility Analysis of Claims Reciting or Involving Laws of Nature/Natural Principles, Natural Phenomena, and/or Natural Products (USPTO memorandum, 4 March, 2014).

  16. Zuhn, D.L. USPTO Holds Forum on Subject Matter Eligibility—Part I (Patent Docs, 12 May 2014).

  17. Zuhn, D.L. USPTO Holds Forum on Subject Matter Eligibility—Part III (Patent Docs, 15 May 2014).

  18. Offit, K. et al. J. Clin. Oncol. 31, 2743–2748 (2013).

    Article  Google Scholar 

  19. Rosenfeld, J.A. & Mason, C.E. Genome Med. 5, 27 (2013).

    CAS  Article  Google Scholar 

  20. Thomson, J.A. US Patent No. 6,200,806 (2001).

  21. Section 27 of Leahy-Smith America Invents Act. Public Law 112-29 (2011).

  22. In re Bilski, 545 F.3d 943 (2008).

Download references


We thank N. Yi-Chen Su for insights into and comments on this article.

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Albert Wai-Kit Chan, Alice Yuen-Ting Wong or Hon-Man Lee.

Ethics declarations

Competing interests

The authors declare competing financial interests: details are available in the online version of the paper (doi:10.1038/nbt.2945).

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Chan, AK., Wong, AT. & Lee, HM. A patent perspective on US stem cell research. Nat Biotechnol 32, 633–637 (2014).

Download citation

  • Published:

  • Issue Date:

  • DOI:

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing